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Monday, March 2, 2009 243amitochondrial redox response to increased work. Isolated cardiomyocytes were
field stimulated and fractional shortening simultaneously recorded with epi-
fluorescence measurements of NAD(P)H and FAD. Cells were paced at
0.5Hz and the stimulation frequency step increased to 1Hz, 2Hz and 3Hz in or-
der to increase work intensity. NAD(P)H was excited at 340nm (fluorescence
collected 455-480nm) and FAD was excited at 430nm (fluorescence collected
505-600nm).
Increasing the stimulation frequency from 0.5Hz to 2Hz and 3Hz, but not 1Hz,
resulted in a decrease in NAD(P)H fluorescence and an increase in FAD fluo-
rescence, indicating oxidation of the cell environment. Reducing work intensity
back to 0.5Hz pacing led to immediate recovery of metabolite fluorescence.
Addition of 2mM NaCN established a completely reduced mitochondrial envi-
ronment, leading to NAD(P)H fluorescence increasing to a maximum and FAD
fluorescence decreasing to a minimum. Subsequent step increase in stimulation
to 3Hz caused no change in NAD(P)H or FAD fluorescence. Treatment with
2mMFCCP established a completely oxidised state, resulting in NAD(P)H fluo-
rescence falling to a minimum and FAD fluorescence increasing to a maximum.
Pacing at 3Hz in this state again led to no change in metabolite fluorescence,
confirming the response to increased work was mitochondrial in origin. In-
creasing stimulation frequency to 3Hz in the presence of the movement uncou-
pler cytochalasin D, minimising cell contraction, also led to no change in
NAD(P)H or FAD fluorescence, thus confirming that contractile work was
the cause of the change in mitochondrial redox state.
In conclusion, the response to increased work intensity in cardiomyocytes is
oxidation of the cell, suggesting that the mitochondria are initially unable to
maintain NAD(P)H/FADH2 supply in order to cope with increased metabolic
demand.
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Background:We have previously shown that the anti-ischemic agent trimeta-
zidine (TMZ) rescued [Ca2þ]i transient and mechanical alternans in ventricular
myocytes from rabbits with non-ischemic heart failure (HF), induced by com-
bined aortic insufficiency and stenosis. The cardioprotective action of TMZ has
been linked to the inhibition of free fatty acid (FFA) oxidation, however the
underlying mechanism remains poorly defined. The aim of this study was to
determine whether the plasma levels of FFA (total ([FFA]tot) and unbound to
albumin ([FFA]u)) are elevated in rabbit HF and whether TMZ affects mito-
chondrial metabolism. Methods and Results: We found that both [FFA]tot
and [FFA]u were significantly elevated in HF rabbits. [FFA]u increased 4-times
during HF (from 1354 to 5357 nM) while the [FFA]tot increased only two-
fold (from 58516 to 121529 mM), demonstrating that [FFA]u is a reliable bio-
marker of HF. Furthermore, using TMRM fluorescence confocal microscopy
and a Strathkelvin micro volume precision respirometry system, we determined
that mitochondrial complex II activity was significantly elevated (þ72%) dur-
ing HF, while complex I activity was decreased (-90%). Cell treatment with
TMZ had no effects on the complex I activity in control (þ6%), while it in-
creased (þ26%) the activity of complex I under HF conditions. Moreover,
TMZ reversed complex II activity in HF myocytes (-55%), while it had no ef-
fect on complex II activity in control cells (-10%). The oxidation of palmitoyl-
carnitine, the upstream substrate for FFA oxidation, was decreased 32% by
TMZ, while TMZ had no effect on complex IV activity. Furthermore,
FADH-mediated auto-fluorescence levels were significantly elevated in HF
myocytes treated with TMZ. Conclusion: TMZ suppresses the elevated activ-
ity of mitochondrial complex II while it increases the depressed activity of
complex I in rabbit HF, and therefore it preserves metabolic reserve of the cell.
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Tallinn, Estonia.The arrangement and movements of mitochondria were quantitatively studied
in adult rat cardiomyocytes and in the cultured continuously dividing non beat-
ing NB HL-1 cells with differentiated cardiac phenotype.
Mitochondria were stained using fluorescent dye MitoTrackerGreen, a dye as-
sociated with inner membrane of mitochondria, and studied by fluorescent con-
focal microscopy. Imaging during different time intervals made it possible to
visualize the 2-dimensional movements and dynamics of cardiac mitochondria.
In adult cardiac cells mitochondria were always arranged very regularly in
a crystal-like manner and did not show any changes in their position during
30 min of low speed scanning. However, high speed scanning (pixel dwell
time 3 ms, time interval between images 400 ms) revealed very rapid fluctua-
tions of the positions of fluorescence centers which followed the pattern of
a random walk movement within the limits of the internal space of mitochon-
dria, most probably due to transitions between condensed and orthodox config-
urational states of matrix and inner membrane as a result of functioning of
transmembrane metabolite carriers. No evidence for mitochondrial fusion or
fission was found in adult cardiomyocytes.
In contrast, in NB HL-1 cells, mitochondria were arranged as a dense tubular
network, in permanent fusion, fission and displacement with high velocity
around 90 nm/s.
The differences observed are related to specific structural organization of the
cells, and most probably due to differences in mitochondria-cytoskeleton orga-
nization. Intracellular local restrictions of diffusion of adenine nucleotides and
metabolic feedback regulation of respiration via phosphotransfer networks are
also different in these cells.
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Cardiac glycosides have been used to treat heart failure for more than 200 years
and their major effect is to inhibit the Naþ/Kþ pump. Inhibition of the pump on
the sarcolemma of cardiac myocytes elevates intracellular Naþ ([Naþ]i), result-
ing in a positive inotropic effect by increasing Ca2þ load. However, our previ-
ous work demonstrated that elevated [Naþ]i impairs mitochondrial energetics
by blunting mitochondrial Ca2þ ([Ca2þ]m) accumulation. Moreover, we
showed that CGP-37157, an inhibitor of [Ca2þ]m efflux, restored [Ca
2þ]m ac-
cumulation and improved mitochondrial energetics. Here, we investigated
the effects of ouabain with or without CGP-37157 on [Naþ]i and NADH pro-
duction in isolated cardiomyocytes and examined the effects on hemodynamics
and Oxygen consumption (mVO2) in whole hearts. Application of ouabain to
isolated myocytes elevated [Naþ]i in a dose-dependent way. During 1 Hz stim-
ulation, the NADH/NADþ redox potential in ouabain treated myocytes was
decreased significantly, whereas NADH levels were well maintained in the
presence of CGP-37157. In whole-heart studies, ouabain increased LVDP,
þdP/dt, and -dP/dt, and addition of CGP-37157 further increased þdP/dt and
-dP/dt. When isoproterenol was employed to increase cardiac work, LVDP
was not increased, but þdP/dt and -dP/dt were increased by 57% and 52%, re-
spectively, in hearts without concomitant CGP-37157 treatment. In isoprotere-
nol-treated hearts also exposed to CGP-37157, LVDP increased by 30%, and
þdP/dt and -dP/dt were increased by 75% and 53%, respectively. Whole heart
mVO2 increased by 18% after ouabain treatment and by 25% after isoprotere-
nol administration compared to baseline. With concomitant CGP-37157 treat-
ment, ouabain increased mVO2 by 32% and isoproterenol increased mVO2 by
53%. Our findings revealed an adverse effect of the glycoside on mitochondrial
energetics and indicate that CGP-37157 can prevent this impairment. In addi-
tion, inotropic responses to both ouabain and isoproterenol were enhanced in
the presence of CGP-37157.
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Ionic equilibria are known to be dramatically altered in failing hearts, as well as
during and after ischemic injury. Ion transport across the mitochondrial inner
membrane has been shown to modulate the energetic performance of mitochon-
dria. Consequently, it is critical to thoroughly understand the interrelationship
between ion fluxes and energetics. With this aim in mind, here we continue to
develop our computational model of mitochondrial energetics to account for
pH regulation, Naþ/Hþ cotransport, and the Pi carrier, and study their effects
on mitochondrial energy production and Ca2þ handling mediated by the Ca2þ
